Alteogen to merge subsidiary Alteogen Biologics into parent company

Bitget2026/10/06 09:09

Alteogen will absorb wholly owned unit Alteogen Biologics, folding clinical, regulatory, marketing functions into a single biopharma operating structure. Merger ratio set at 1 Alteogen share to 0.1679581 shares for each Alteogen Biologics common share held. Alteogen expects 600,477 new common shares to be issued, about 0.86% dilution versus current shares outstanding. Closing targeted for Dec. 29, 2026; new shares slated to list on Jan. 25, 2027. Alteogen Biologics posted 2025 revenue of 8,312,613,191 won, net profit of 23,398,449,406 won, assets of 88,971,988,092 won. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alteogen Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261006000420), on October 06, 2026, and is solely responsible for the information contained therein.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Alteogen will absorb wholly owned unit Alteogen Biologics, folding clinical, regulatory, marketing functions into a single biopharma operating structure.
Merger ratio set at 1 Alteogen share to 0.1679581 shares for each Alteogen Biologics common share held.
Alteogen expects 600,477 new common shares to be issued, about 0.86% dilution versus current shares outstanding.
Closing targeted for Dec. 29, 2026; new shares slated to list on Jan. 25, 2027.
Alteogen Biologics posted 2025 revenue of 8,312,613,191 won, net profit of 23,398,449,406 won, assets of 88,971,988,092 won.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alteogen Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261006000420), on October 06, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

A new twist has emerged in the US AI data center investment boom. SoftBank is preparing for cooling US demand and a deteriorating political environment, and does not rule out shifting data center construction priorities to other countries. As cross-border computing power delivery capability improves and investment returns come under question, the logic behind AI infrastructure expansion is loosening, and over $3.5 trillion in infrastructure investment now faces potential impairment risks.

华尔街见闻•2026/11/09 10:26